{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:33:32Z","timestamp":1790717612329,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.drudis.2020.10.011","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:24:10Z","timestamp":1603157050000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance"],"prefix":"10.1016","volume":"26","author":[{"given":"Kushal","family":"Vanamala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katyayani","family":"Tatiparti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketki","family":"Bhise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaresh","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H.","family":"Scheetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.10.011_bib0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drudis.2020.10.011_bib0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinte.1941.00200110003001","article-title":"Significance of bacteremia caused by Staphylococcus aureus","volume":"68","author":"Skinner","year":"1941","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drudis.2020.10.011_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM198905043201806","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"320","author":"Brumfitt","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.10.011_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.meegid.2008.07.007","article-title":"The evolution of Staphylococcus aureus","volume":"8","author":"Deurenberg","year":"2008","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0030","series-title":"Antibiotic Resistance Threats in the United States","author":"CDC","year":"2019"},{"key":"10.1016\/j.drudis.2020.10.011_bib0035","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0045","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Hirenkumar","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.drudis.2020.10.011_bib0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2020.10.011_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4657396","article-title":"Biofilm formation by methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains from hospitalized patients in Poland","volume":"2018","author":"Piechota","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.drudis.2020.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1039\/C9MD00044E","article-title":"Methicillin-resistant: Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype","volume":"10","author":"Craft","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.drudis.2020.10.011_bib0065","doi-asserted-by":"crossref","first-page":"S175.e9","DOI":"10.1016\/j.ajic.2008.10.002","article-title":"Effect of antibacterials on biofilms","volume":"36","author":"Aslam","year":"2008","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.drudis.2020.10.011_bib0070","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.4049\/jimmunol.1202348","article-title":"Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections","volume":"190","author":"Hanke","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13756-017-0192-1","article-title":"MRSA decolonization failure-are biofilms the missing link?","volume":"6","author":"G\u00fcnther","year":"2017","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.drudis.2020.10.011_bib0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-0711-4-2","article-title":"In vitro activity of vancomycin, quinupristin\/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci","volume":"4","author":"El-Azizi","year":"2005","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.drudis.2020.10.011_bib0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0095","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3389\/fmicb.2018.01396","article-title":"Bacterial memory of persisters: Bacterial persister cells can retain their phenotype for days or weeks after withdrawal from colony-biofilm culture","volume":"9","author":"Miyaue","year":"2018","journal-title":"Front Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2020.10.011_bib0105","series-title":"Microbiology Guide to Interpreting Minimum Inhibitory Concentration","author":"Idexx","year":"2019"},{"key":"10.1016\/j.drudis.2020.10.011_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.2042-7158.2010.01183.x","article-title":"Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis","volume":"63","author":"Salem","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0115","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1021\/nn3012042","article-title":"Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting","volume":"6","author":"Ojea-Jim\u00e9nez","year":"2012","journal-title":"ACS Nano."},{"key":"10.1016\/j.drudis.2020.10.011_bib0120","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/AAC.01728-08","article-title":"Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm","volume":"53","author":"Stewart","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijantimicag.2007.11.012","article-title":"Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp","volume":"31","author":"Roveta","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.drudis.2020.10.011_bib0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bjid.2019.05.006","article-title":"Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review","volume":"23","author":"Telles","year":"2019","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0135","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1128\/AAC.00735-16","article-title":"New insight into daptomycin bioavailability and localization in Staphylococcus aureus biofilms by dynamic fluorescence imaging","volume":"60","author":"Boudjemaa","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0140","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00181-13","article-title":"A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms","volume":"57","author":"Bauer","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0145","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/AAC.02764-13","article-title":"A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm- producing methicillin-resistant Staphylococcus aureus","volume":"58","author":"Barber","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0150","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/AAC.00134-09","article-title":"Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis","volume":"53","author":"LaPlante","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin activity","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0160","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.anaerobe.2011.11.005","article-title":"Effect of new antimicrobial agents on the ecological balance of human microflora","volume":"18","author":"Rashid","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.drudis.2020.10.011_bib0170","first-page":"1920","article-title":"Antibiotic misuse: a global crisis","volume":"174","author":"Bell","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2020.10.011_bib0175","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1166\/jnn.2014.9527","article-title":"The role of nanotechnology in combating multi-drug resistant bacteria","volume":"14","author":"Singh","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0180","series-title":"Antimicrobial Resistance","author":"WHO","year":"2000"},{"key":"10.1016\/j.drudis.2020.10.011_bib0185","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2020.10.011_bib0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2007.10.027","article-title":"Delivery systems to increase the selectivity of antibiotics in phagocytic cells","volume":"125","author":"Briones","year":"2008","journal-title":"J. Control Release"},{"key":"10.1016\/j.drudis.2020.10.011_bib0195","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1093\/cid\/civ819","article-title":"The regulatory pathway for antifungal drugs: a US perspective","volume":"61","author":"Tillotson","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3947\/ic.2016.48.4.267","article-title":"Treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"48","author":"Choo","year":"2016","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0205","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/AAC.00224-11","article-title":"Striking \u2018seesaw effect\u2019 between daptomycin nonsusceptibility and beta-lactam susceptibility in Staphylococcus haemolyticus","volume":"55","author":"Vignaroli","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.01204-13","article-title":"\u03b2-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone","volume":"58","author":"Dilworth","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0215","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000093269","article-title":"Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically III patients","volume":"52","author":"Malacarne","year":"2006","journal-title":"Chemotherapy"},{"key":"10.1016\/j.drudis.2020.10.011_bib0220","first-page":"174","article-title":"Nephrotoxicity with combination vancomycin-aminoglycoside therapy","volume":"10","author":"Timpe","year":"2005","journal-title":"J Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.10.011_bib0225","first-page":"3976","article-title":"Daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus endocarditis","volume":"60","author":"Chambers","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0230","doi-asserted-by":"crossref","first-page":"e02074","DOI":"10.1128\/AAC.02074-19","article-title":"Impact of daptomycin dose exposure alone or in combination with \u03b2-lactams or rifampin against vancomycin-resistant enterococci in an in vitro biofilm model","volume":"64","author":"Jahanbakhsh","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0235","doi-asserted-by":"crossref","first-page":"ftw042","DOI":"10.1093\/femspd\/ftw042","article-title":"Synergistic activity between an antimicrobial polyacrylamide and daptomycin versus Staphylococcus aureus biofilm","volume":"74","author":"Siala","year":"2016","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0240","doi-asserted-by":"crossref","first-page":"ftw019","DOI":"10.1093\/femspd\/ftw019","article-title":"Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro","volume":"74","author":"J\u00f8rgensen","year":"2016","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40121-014-0055-5","article-title":"Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis in a novel in vitro PK\/PD model of bacterial biofilm","volume":"4","author":"Hall Snyder","year":"2015","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.drudis.2020.10.011_bib0250","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3389\/fmicb.2018.00572","article-title":"Differential activity of the combination of vancomycin and amikacin on planktonic vs. biofilm-growing Staphylococcus aureus bacteria in a Hollow Fiber infection model","volume":"9","author":"Broussou","year":"2018","journal-title":"Front Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0255","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1128\/AAC.01236-13","article-title":"In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus","volume":"57","author":"Tang","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0260","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1590\/S0037-86822012000400011","article-title":"Rifampicin fails to eradicate mature biofilm formed by methicillin-resistant Staphylococcus aureus","volume":"45","author":"Reiter","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.drudis.2020.10.011_bib0265","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2020.10.011_bib0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and \u03b2-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0280","series-title":"Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis","author":"WHO","year":"2017"},{"key":"10.1016\/j.drudis.2020.10.011_bib0285","series-title":"Drug Resistance Threats","author":"CDC","year":"2017"},{"key":"10.1016\/j.drudis.2020.10.011_bib0290","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0295","series-title":"Lack of New Antibiotics Threatens Global Efforts to Contain Drug-Resistant Infections","author":"WHO","year":"2020"},{"key":"10.1016\/j.drudis.2020.10.011_bib0300","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10\u00d7\u201820 progress - development of new drugs active against Gram-negative bacilli: an update from the infectious diseases society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.10.011_bib0305","first-page":"19","article-title":"Antibiotics \u2014 from there to where? How the antibiotic miracle is threatened by resistance and a broken market and what we can do about it","volume":"3","author":"Bradford","year":"2018","journal-title":"Pathog Immun."},{"key":"10.1016\/j.drudis.2020.10.011_bib0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2020.10.011_bib0315","series-title":"Antibiotics: The Perfect Storm","author":"Schlaes","year":"2010"},{"key":"10.1016\/j.drudis.2020.10.011_bib0320","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11481-006-9032-4","article-title":"Nanotechnology: A focus on nanoparticles as a drug delivery system","volume":"1","author":"Kingsley","year":"2006","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0325","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1096\/fj.14-255786","article-title":"Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes","volume":"28","author":"Edagwa","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2020.10.011_bib0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2014.05.034","article-title":"Biodegradable nanoparticles for intracellular delivery of antimicrobial agents","volume":"187","author":"Xie","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.drudis.2020.10.011_bib0335","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/jac\/dkq318","article-title":"Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice","volume":"65","author":"Destache","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0340","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/AEM.06513-11","article-title":"Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus","volume":"78","author":"Brown","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0345","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1039\/c3nr01990j","article-title":"Multiple strategies to activate gold nanoparticles as antibiotics","volume":"5","author":"Zhao","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2020.10.011_bib0350","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1002\/jps.21372","article-title":"Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors","volume":"97","author":"Shaik","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.10.011_bib0355","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv Rev."},{"key":"10.1016\/j.drudis.2020.10.011_bib0360","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijpharm.2012.07.033","article-title":"In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus","volume":"436","author":"Chakraborty","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.10.011_bib0365","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1038\/srep22595","article-title":"An unexpected transient breakdown of the blood brain barrier triggers passage of large intravenously administered nanoparticles","volume":"6","author":"Smith","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2020.10.011_bib0370","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1039\/C8RA00154E","article-title":"Immune response effects of diverse vaccine antigen attachment ways based on the self-made nanoemulsion adjuvant in systemic MRSA infection","volume":"8","author":"Yang","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.drudis.2020.10.011_bib0375","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41598-018-37194-2","article-title":"Peptidoglycan binding protein (PGBP)-modified magnetic nanobeads for efficient magnetic capturing of Staphylococcus aureus associated with sepsis in blood","volume":"9","author":"Lim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2020.10.011_bib0380","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1021\/acsnano.7b00041","article-title":"Bacteria-activated theranostic nanoprobes against methicillin-resistant Staphylococcus aureus infection","volume":"11","author":"Zhao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.drudis.2020.10.011_bib0385","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01715542","article-title":"Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin","volume":"22","author":"Onyeji","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.drudis.2020.10.011_bib0390","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijantimicag.2010.10.011","article-title":"Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA)","volume":"37","author":"Pumerantz","year":"2011","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.drudis.2020.10.011_bib0395","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/jac\/dks212","article-title":"Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model","volume":"67","author":"Sande","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u2018Nanoantibiotics\u2019: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Huh","year":"2011","journal-title":"J. Control Release."},{"key":"10.1016\/j.drudis.2020.10.011_bib0405","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhin.2003.12.003","article-title":"Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection","volume":"56","author":"Garske","year":"2004","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.drudis.2020.10.011_bib0410","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults","volume":"69","author":"Kim","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0415","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jmii.2012.03.009","article-title":"Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus","volume":"46","author":"Wu","year":"2013","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.drudis.2020.10.011_bib0420","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nano.2007.03.003","article-title":"Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles","volume":"3","author":"Esmaeili","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2020.10.011_bib0425","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11051-010-0037-9","article-title":"Evaluation of the antibacterial activity of poly-(D,L-lactide-co-glycolide) nanoparticles containing violacein","volume":"13","author":"Martins","year":"2011","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.drudis.2020.10.011_bib0430","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00011-011-0402-x","article-title":"Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits","volume":"61","author":"Jiang","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.drudis.2020.10.011_bib0435","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.drudis.2020.10.011_bib0440","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2006.03.014","article-title":"Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres","volume":"317","author":"Cevher","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.10.011_bib0445","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1128\/AAC.49.7.3025-3027.2005","article-title":"In vitro and In vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(\u03b5-caprolactone) microparticles","volume":"49","author":"le Ray","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.10.011_bib0450","first-page":"4351","article-title":"Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms","volume":"10","author":"Ferreira","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drudis.2020.10.011_bib0455","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbm.b.32747","article-title":"Poly (\u03b5-caprolactone) coating delays vancomycin delivery from porous chitosan\/\u03b2-tricalcium phosphate composites","volume":"100","author":"Fang","year":"2012","journal-title":"J. Biomed. Mater. Res. B"},{"key":"10.1016\/j.drudis.2020.10.011_bib0460","doi-asserted-by":"crossref","first-page":"e7804","DOI":"10.1371\/journal.pone.0007804","article-title":"Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection","volume":"4","author":"Han","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.011_bib0465","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1167\/iovs.10-5388","article-title":"Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin","volume":"51","author":"Durairaj","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2020.10.011_bib0470","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1088\/0957-4484\/16\/10\/059","article-title":"The bactericidal effect of silver nanoparticles","volume":"16","author":"Morones","year":"2005","journal-title":"Nanotechnology"},{"key":"10.1016\/j.drudis.2020.10.011_bib0475","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.colsurfb.2010.05.018","article-title":"Synthesis of antimicrobial silver nanoparticles by callus and leaf extracts from saltmarsh plant, Sesuvium portulacastrum","volume":"79","author":"Nabikhan","year":"2010","journal-title":"L. Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.drudis.2020.10.011_bib0480","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1016\/S1452-3981(23)19488-0","article-title":"Electrochemical behaviour of apoferritin encapsulating of silver (i) ions and its application for treatment of Staphylococcus aureus","volume":"7","author":"Provaznik","year":"2012","journal-title":"Int. J. Electrochem. Sci."},{"key":"10.1016\/j.drudis.2020.10.011_bib0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nano.2011.05.007","article-title":"Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria","volume":"8","author":"Guzman","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2020.10.011_bib0490","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12989-017-0209-1","article-title":"Comparison between micro-and nanosized copper oxide and water soluble copper chloride: interrelationship between intracellular copper concentrations, oxidative stress and DNA damage response in human lung cells","volume":"14","author":"Strauch","year":"2017","journal-title":"Part Fibre Toxicol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0495","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1046\/j.1365-2672.92.5s1.7.x","article-title":"Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria","volume":"92","author":"Lambert","year":"2002","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0500","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1007\/s12274-018-2143-4","article-title":"Aminosaccharide-gold nanoparticle assemblies as narrow-spectrum antibiotics against methicillin-resistant Staphylococcus aureus","volume":"11","author":"Yang","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.drudis.2020.10.011_bib0505","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1039\/C7RA05040B","article-title":"Biomimetically synthesized ZnO nanoparticles attain potent antibacterial activity against less susceptible S. aureus skin infection in experimental animals","volume":"7","author":"Rauf","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.drudis.2020.10.011_bib0510","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s11274-011-0966-1","article-title":"Characterization of clinical strains of MSSA, MRSA and MRSE isolated from skin and soft tissue infections and the antibacterial activity of ZnO nanoparticles","volume":"28","author":"Ansari","year":"2012","journal-title":"World J. Microbiol Biotechnol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0515","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.5958\/0974-360X.2018.00350.5","article-title":"Evaluation of antibacterial activity of zinc oxide nanoparticles against biofilm producing methicillin resistant Staphylococcus aureus (MRSA)","volume":"11","author":"Umamageswari","year":"2018","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0520","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1039\/C7NR08499D","article-title":"Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant: Staphylococcus aureus (MRSA)","volume":"10","author":"Kadiyala","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2020.10.011_bib0525","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13204-014-0301-x","article-title":"Antimicrobial activity of zinc and titanium dioxide nanoparticles against biofilm-producing methicillin-resistant Staphylococcus aureus","volume":"5","author":"Jesline","year":"2015","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.drudis.2020.10.011_bib0530","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40097-016-0205-2","article-title":"Antibiofilm activity of biogenic copper and zinc oxide nanoparticles-antimicrobials collegiate against multiple drug resistant bacteria: a nanoscale approach","volume":"6","author":"Ashajyothi","year":"2016","journal-title":"J. Nanostruct. Chem."},{"key":"10.1016\/j.drudis.2020.10.011_bib0535","first-page":"901","article-title":"Potentiating efficacy of antibiotic conjugates with zinc oxide nanoparticles against clinical isolates of Staphylococcus aureus","volume":"10","author":"Iram","year":"2015","journal-title":"Dig. J. Nanomater. Biostruct."},{"key":"10.1016\/j.drudis.2020.10.011_bib0540","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4236\/jbnb.2010.11005","article-title":"Effect of nano-titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus","volume":"01","author":"Roy","year":"2010","journal-title":"J. Biomater. Nanobiotechnol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176988","article-title":"Antibiofilm and antibacterial effects of specific chitosan molecules on Staphylococcus aureus isolates associated with bovine mastitis","volume":"12","author":"Asli","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.011_bib0550","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1570159X11311020006","article-title":"Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system","volume":"11","author":"Zou","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0555","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","article-title":"Mechanisms in photodynamic therapy: Part one - Photosensitizers, photochemistry and cellular localization","volume":"1","author":"Castano","year":"2004","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.drudis.2020.10.011_bib0560","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0885328209352701","article-title":"Antimicrobial properties of light-activated polyurethane containing indocyanine green","volume":"25","author":"Perni","year":"2011","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.drudis.2020.10.011_bib0565","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1021\/ja111110e","article-title":"Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection","volume":"133","author":"Pornpattananangkul","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2020.10.011_bib0570","doi-asserted-by":"crossref","first-page":"e0220684","DOI":"10.1371\/journal.pone.0220684","article-title":"Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA)","volume":"14","author":"Hibbitts","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.011_bib0575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrg2749","article-title":"CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea","volume":"11","author":"Marraffini","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drudis.2020.10.011_bib0580","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/bc200333w","article-title":"Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy","volume":"23","author":"Kubo","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.drudis.2020.10.011_bib0585","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2017.09.012","article-title":"Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications","volume":"266","author":"Liu","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.drudis.2020.10.011_bib0590","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1189\/jlb.72.3.417","article-title":"Macrophages in gene therapy: cellular delivery vehicles and in vivo targets","volume":"72","author":"Burke","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0595","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41467-018-04390-7","article-title":"Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus","volume":"9","author":"Kim","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2020.10.011_bib0600","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/ma11020321","article-title":"Emerging nanomedicine therapies to counter the rise of Methicillin-resistant Staphylococcus aureus","volume":"11","author":"Hibbitts","year":"2018","journal-title":"Materials"},{"key":"10.1016\/j.drudis.2020.10.011_bib0605","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11908-017-0605-6","article-title":"Trends in community versus health care-acquired methicillin-resistant Staphylococcus aureus infections","volume":"19","author":"Calfee","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.drudis.2020.10.011_bib0610","doi-asserted-by":"crossref","first-page":"e62117","DOI":"10.1371\/journal.pone.0062117","article-title":"Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California","volume":"8","author":"Hudson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.10.011_bib0615","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-62703-664-1_18","article-title":"Animal models in drug development for MRSA","volume":"1085","author":"Marra","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drudis.2020.10.011_bib0620","doi-asserted-by":"crossref","first-page":"MR17","DOI":"10.1116\/1.2815690","article-title":"Nanomaterials and nanoparticles: sources and toxicity","volume":"2","author":"Buzea","year":"2007","journal-title":"Biointerphases"},{"key":"10.1016\/j.drudis.2020.10.011_bib0625","first-page":"1527","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"Ageing Int."},{"key":"10.1016\/j.drudis.2020.10.011_bib0630","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.drudis.2020.10.011_bib0635","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ja.2017.124","article-title":"Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps","volume":"70","author":"Simpkin","year":"2017","journal-title":"J. Antibiot."},{"key":"10.1016\/j.drudis.2020.10.011_bib0640","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2174\/1381612821666150310104416","article-title":"Drug repurposing for the treatment of staphylococcal infections","volume":"21","author":"Thangamani","year":"2015","journal-title":"Curr. Pharm. Des."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620304281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620304281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:46:41Z","timestamp":1761223601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620304281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1359644620304281"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.10.011","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}